Literature DB >> 24960590

Characterization of the protein Z-dependent protease inhibitor interactive-sites of protein Z.

Shabir H Qureshi1, Qiuya Lu1, Chandrashekhara Manithody1, Likui Yang1, Alireza R Rezaie2.   

Abstract

BACKGROUND: Protein Z (PZ) has been reported to promote the inactivation of factor Xa (FXa) by PZ-dependent protease inhibitor (ZPI) by about three orders of magnitude. Previously, we prepared a chimeric PZ in which its C-terminal pseudo-catalytic domain was grafted on FX light-chain (Gla and EGF-like domains) (PZ/FX-LC). Characterization of PZ/FX-LC revealed that the ZPI interactive-site is primarily located within PZ pseudo-catalytic domain. Nevertheless, the cofactor function and apparent Kd of PZ/FX-LC for interaction with ZPI remained impaired ~6-7-fold, suggesting that PZ contains a ZPI interactive-site outside pseudo-catalytic domain. X-ray structural data indicates that Tyr-240 of ZPI interacts with EGF2-domain of PZ. Structural data further suggests that 3 other ZPI surface loops make salt-bridge interactions with PZ pseudo-catalytic domain. To identify ZPI interactive-sites on PZ, we grafted the N-terminal EGF2 subdomain of PZ onto PZ/FX-LC chimera (PZ-EGF2/FX-LC) and also generated two compensatory charge reversal mutants of PZ pseudo-catalytic domain (Glu-244 and Arg-212) and ZPI surface loops (Lys-239 and Asp-293).
METHODS: PZ chimeras were expressed in mammalian cells and ZPI derivatives were expressed in Escherichia coli.
RESULTS: The PZ EGF2 subdomain fusion restored the defective cofactor function of PZ/FX-LC. The activities of PZ and ZPI mutants were all impaired if assayed individually, but partially restored if the compensatory charge reversal mutants were used in the assay.
CONCLUSIONS: PZ EGF2 subdomain constitutes an interactive-site for ZPI. Data with compensatory charge reversal mutants validates structural data that the identified residues are part of interactive-sites. GENERAL SIGNIFICANCE: Insight is provided into mechanisms through which specificity of ZPI-PZ-FXa complex formation is determined.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Factor Xa; Mutagenesis; Protein Z; Protein Z-dependent protease inhibitor; Serpin

Mesh:

Substances:

Year:  2014        PMID: 24960590      PMCID: PMC4118583          DOI: 10.1016/j.bbapap.2014.06.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  Structure of a serpin-protease complex shows inhibition by deformation.

Authors:  J A Huntington; R J Read; R W Carrell
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

2.  Three-dimensional structure of the apo form of the N-terminal EGF-like module of blood coagulation factor X as determined by NMR spectroscopy and simulated folding.

Authors:  M Ullner; M Selander; E Persson; J Stenflo; T Drakenberg; O Teleman
Journal:  Biochemistry       Date:  1992-07-07       Impact factor: 3.162

Review 3.  Structure-function relationships of epidermal growth factor modules in vitamin K-dependent clotting factors.

Authors:  J Stenflo
Journal:  Blood       Date:  1991-10-01       Impact factor: 22.113

4.  Primary structure of vitamin K-dependent human protein Z.

Authors:  H Sejima; T Hayashi; Y Deyashiki; J Nishioka; K Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1990-09-14       Impact factor: 3.575

5.  Basis for the specificity and activation of the serpin protein Z-dependent proteinase inhibitor (ZPI) as an inhibitor of membrane-associated factor Xa.

Authors:  Xin Huang; Alexey Dementiev; Steven T Olson; Peter G W Gettins
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

6.  Characterization of the protein Z-dependent protease inhibitor.

Authors:  X Han; R Fiehler; G J Broze
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

7.  Structural basis for catalytic activation of protein Z-dependent protease inhibitor (ZPI) by protein Z.

Authors:  Xin Huang; Yahui Yan; Yizheng Tu; Jeffrey Gatti; George J Broze; Aiwu Zhou; Steven T Olson
Journal:  Blood       Date:  2012-07-11       Impact factor: 22.113

8.  Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor.

Authors:  A Tabatabai; R Fiehler; G J Broze
Journal:  Thromb Haemost       Date:  2001-04       Impact factor: 5.249

9.  Residues of the 39-loop restrict the plasma inhibitor specificity of factor IXa.

Authors:  Likui Yang; Alireza R Rezaie
Journal:  J Biol Chem       Date:  2013-03-25       Impact factor: 5.157

10.  Crystal structure of protein Z-dependent inhibitor complex shows how protein Z functions as a cofactor in the membrane inhibition of factor X.

Authors:  Zhenquan Wei; Yahui Yan; Robin W Carrell; Aiwu Zhou
Journal:  Blood       Date:  2009-06-15       Impact factor: 22.113

View more
  2 in total

1.  Phosphatidylserine and Phosphatidylethanolamine Bind to Protein Z Cooperatively and with Equal Affinity.

Authors:  Tanusree Sengupta; Narayanan Manoj
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

2.  The serine protease homolog spheroide is involved in sensing of pathogenic Gram-positive bacteria.

Authors:  Jelena Patrnogic; Vincent Leclerc
Journal:  PLoS One       Date:  2017-12-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.